Mizuho Reiterates Arcutis Biotherapeutics (ARQT) Buy Recommendation
25/9 22:16
Fintel reports that on September 25, 2023, Mizuho reiterated coverage of Arcutis Biotherapeutics (NASDAQ:ARQT) with a Buy recommendation....
25/9 22:16
Fintel reports that on September 25, 2023, Mizuho reiterated coverage of Arcutis Biotherapeutics (NASDAQ:ARQT) with a Buy recommendation....